Navigation Links
Qualyst Transporter Solutions, LLC Announces New Alliance with GenoMembrane
Date:1/21/2013

RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2013 /PRNewswire-iReach/ -- Qualyst Transporter Solutions, LLC, has recently announced an alliance with GenoMembrane, Kanagawa, Japan to make available its B-CLEAR® Technology to customers in Japan.  The initial offering will focus on supplying B-CLEAR® kits of rat and human hepatocytes, both plated with Transporter Certified™ hepatocytes.  In addition, contract services projects can be facilitated through GenoMembrane.  The alliance will facilitate access to B-CLEAR® technology in Japan, which can be used to predict the biliary excretion of drugs, evaluate clinically relevant drug interactions, determine the cholestatic potential of drugs, and estimate their intracellular concentration.

"B-CLEAR® human kits for Japan use cryopreserved human hepatocytes that have been certified for transporter function (uptake and efflux), providing the customer with clinically relevant data, and a high level of reproducibility from experiment to experiment." said Dr. Christopher Black , CEO for Qualyst Transporter Solutions.

Qualyst Transporter Solutions only uses Transporter Certified™ hepatocytes in its kits and services to examine the potential for in vivo relevant transporter-based drug interactions.  The key to obtaining in vivo-relevant answers is to use a fully integrated, functioning cell system that has been certified for transporter function.  "We certify our hepatocytes to ensure a fully functioning complement of uptake and efflux transporters, which guarantees that the results are in vivo-relevant," said Dr. Kenneth Brouwer , CSO for Qualyst Transporter Solutions.

"We are excited that we can now offer B-CLEAR® kits with both rat and human hepatocytes to our Japanese customers, as well as an opportunity to offer other relevant research services conducted by Qualyst Transporter Solutions," said Mr. Satoshi Senda , CEO for GenoMembrane.

About Qualyst Transporter Solutions, LLC
In addition to it's patented B-CLEAR® technology, Qualyst Transporter Solutions commercializes novel and proprietary drug transport and hepatobiliary disposition products for drug discovery and development.  Qualyst Transporter Solutions products provide answers to transporter questions that arise in drug discovery and development.  For additional information, please refer to the company's web site at www.qualyst.com or call (919) 313-6500.  B-CLEAR® technology is covered by US (# 6780580), EU (#1163517) and JP (#4451570) patents issued and pending.

About GenoMembrane
GenoMembrane Co., Ltd. provides transporter-related products and services that are critical in the development and design of novel drugs for clinical applications.  GenoMembrane also provides research tools and collaborates for the pharmacological evaluation of drug candidates to minimize costs, help improve the success rate of candidate drugs, and speed up new drug development. For additional information, please refer to the company's web site at http://www.genomembrane.com/.

Media Contact

US:  Qualyst Transporter Solutions, Christopher Black , Ph.D. Chief Executive Officer, (919) 313-6511, information@qualyst.com

Japan: GenoMembrane, Satoshi Senda , Chief Executive Officer, +81(45)508-2326, info@genomembrane.com

Media Contact: Christopher Black Qualyst Transporter Solutions, LLC, 9192978681, chrisblack@qualyst.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Qualyst Transporter Solutions, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Absorption Systems announces novel test platform for interactions with the BCRP transporter
2. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
3. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
4. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
5. Pristine Solutions, Inc. Completes Acquisition of Eaton Scientific Systems, Ltd. - Enters Multi-Billion Dollar Womens Health and Drug Sector
6. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
7. Cardiosolutions, Inc. Gathers Major Investment from Sorin Group
8. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
9. Block Engineering Announces Collaborative Agreement with Pfizer for Next Generation Cleaning Verification Technology
10. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
11. Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
(Date:4/27/2016)... -- Tie-up with Government hospitals as part ... save newborns   Fortis La Femme, ... with Breast Milk Foundation (BMF), a non-profit organization within the ... ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that breast ... should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... Massachusetts , April 27, 2016 ... that Jeff Poulton , Chief Financial Officer, will present ... Boston, MA on Wednesday, May 04, ... audio webcast will be available on the Presentations and Webcasts ... a replay of the webcast will be available on this ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... Zitter Health ... Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies for their achievements in ... Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will be ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... ... , ... TeleMedCo™, a new company developing real time technology ... rapid diagnosis, triage and admission of patients leveraging IBM Watson’s software and healthcare ... the first time at GENBAND’s Perspectives16 conference. , TeleMedCo selected GENBAND’s Kandy ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is ... Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a test of ... on provider-administered drugs while preserving care provided to beneficiaries. The webinar will review the ...
(Date:5/2/2016)... Beach, FL (PRWEB) , ... May 02, 2016 , ... ... to great pain and suffering. With no cure, most patients must deal with prescription ... a free coupon card, allowing up to 75% savings at the pharmacy on many ...
Breaking Medicine News(10 mins):